Why Marijuana Stock Cronos Group Shot 8% Higher on Friday
The stock of Cronos Group (NASDAQ: CRON) ended the week on a high note, rising more than 8% on Friday to outpace the gains of the broader market. The catalyst seemed to be various media reports of a medical study indicating cannabidiol (CBD) might be useful in fighting COVID-19. Cronos has a major CBD asset in its Lord Jones product line.
Image source: Getty Images.
Although the results of the study, conducted by researchers at the University of Lethbridge in Canada, were published last month, they are only now hitting the news media and getting on the radar of investors.
Source Fool.com
